Skip to main content
Erschienen in: Advances in Therapy 8/2021

31.03.2021 | Original Research

Humanistic and Economic Burden of Blindness Associated with Retinal Disorders in a Brazilian Sample: A Cross-Sectional Study

verfasst von: Nilceia Lopes, Leticia Lucia dos Santos Dias, Marcos Ávila, Ricardo Miguel Japiassú, Cristina Muccioli, Arnaldo Furman Bordon, Tiago Eugênio Arantes, Tatiana Tanaka, João Jorge Nassaralla Júnior, Antonio Marcelo Casella, Márcio Bittar Nehemy, Magno Ferreira, Rogério Furquim Mauad

Erschienen in: Advances in Therapy | Ausgabe 8/2021

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Vision impairment and blindness have been significantly associated with high medical care expenditures, decrease in health utility, and loss or reduction of productivity. The objective of this study was to assess the humanistic and economic burden of blindness in a Brazilian sample from a societal perspective.

Methods

Cross-sectional, observational, and multicenter study enrolling individuals with blindness (defined as the best corrected visual acuity less than 6/60 in the better-seeing eye) caused by retinal disorders. Data collection was performed between December 2012 and December 2014 through face-to-face interview using a structured questionnaire and three standardized patient-reported outcomes instruments. Direct costs were estimated by multiplying the amount of resources used (12-month recall period) by the corresponding unit cost. Productivity losses were measured using the human capital method. All data were collected in Brazilian real (BRL) and converted to United States dollar (USD), using the exchange rate of 1 USD = 3.0415 BRL (May 7, 2015).

Results

A total of 146 subjects from 17 research sites were included with a mean age of 68 (SD = 14.8) years and equal gender distribution. Blindness negatively affected both general and vision-specific health-related quality of life. One-half of patients presented some level of anxiety and depression; of these, about 50% with moderate or severe symptoms. Around one-third of subjects (34.2%) reported at least one fall in the previous 12 months due to vision impairment; of these subjects, 14% reported fractures. Emergency room visits and hospitalization were reported by around 25% and 5% of subjects, respectively. The short-term costs (annual costs) of severe vision impairment or blindness for the studied subjects was USD 128,389.09 (USD 879.37 per person). Total medical direct costs summed USD 116,182.00 (USD 795.77 per person), 61.7% of which was due to outpatient visits (with physicians and other healthcare professionals). The long-term costs (lifetime productivity loss) totalized USD 1,962,599.50 (USD 13,442.47 per person).

Conclusion

This study demonstrated that blindness imposes both humanistic and economic burden for individuals and for Brazilian society. It also pointed out that there is room to improve blindness management, especially for the poorest people, including health education for individuals, availability of services, and reduction of barriers to patients’ access to healthcare assistance. This was a good starting point; however, further research is needed.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Ackland P, Resnikoff S, Bourne R. Global eye health data. World blindness and visual impairment: despite many successes, the problem is growing. Community Health Eye J. 2017;30(100):70–3. Ackland P, Resnikoff S, Bourne R. Global eye health data. World blindness and visual impairment: despite many successes, the problem is growing. Community Health Eye J. 2017;30(100):70–3.
4.
Zurück zum Zitat IBGE - Instituto Brasileiro de Geografia e Estatística. Pesquisa nacional de saúde: 2013: ciclos de vida: Brasil e grandes regiões/IBGE, Coordenação de Trabalho e Rendimento. - Rio de Janeiro: IBGE, 2015; 2015. 92 p. IBGE - Instituto Brasileiro de Geografia e Estatística. Pesquisa nacional de saúde: 2013: ciclos de vida: Brasil e grandes regiões/IBGE, Coordenação de Trabalho e Rendimento. - Rio de Janeiro: IBGE, 2015; 2015. 92 p.
7.
Zurück zum Zitat Salomão SR, Mitsuhiro MRKH, Belfort R Jr. Visual impairment and blindness: an overview of prevalence and causes in Brazil. An Acad Bras Cienc. 2009;81(3):539–49.CrossRef Salomão SR, Mitsuhiro MRKH, Belfort R Jr. Visual impairment and blindness: an overview of prevalence and causes in Brazil. An Acad Bras Cienc. 2009;81(3):539–49.CrossRef
8.
Zurück zum Zitat Arieta CEL, Fornazari de Oliveira D, de Carvalho Lupinacci AP, et al. Cataract remains an important cause of blindness in Campinas, Brazil. Ophthalmic Epidemiol. 2009;16(1):58–63.CrossRef Arieta CEL, Fornazari de Oliveira D, de Carvalho Lupinacci AP, et al. Cataract remains an important cause of blindness in Campinas, Brazil. Ophthalmic Epidemiol. 2009;16(1):58–63.CrossRef
9.
Zurück zum Zitat Rein DB, Zhang P, Wirth KE, et al. The economic burden of major adult visual disorders in the United States. Arch Ophthalmol. 2006;124:1754–60.CrossRef Rein DB, Zhang P, Wirth KE, et al. The economic burden of major adult visual disorders in the United States. Arch Ophthalmol. 2006;124:1754–60.CrossRef
12.
Zurück zum Zitat Ware J Jr, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220–33.CrossRef Ware J Jr, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220–33.CrossRef
13.
Zurück zum Zitat Simão LM, Lana-Peixoto MA, Araújo CR, Moreira MA, Teixeira AL. The Brazilian version of the 25- item national eye institute visual function questionnaire: translation, reliability and validity. Arq Bras Oftalmol. 2008;71(4):540–6.CrossRef Simão LM, Lana-Peixoto MA, Araújo CR, Moreira MA, Teixeira AL. The Brazilian version of the 25- item national eye institute visual function questionnaire: translation, reliability and validity. Arq Bras Oftalmol. 2008;71(4):540–6.CrossRef
14.
Zurück zum Zitat Mangione CM, Lee PP, Gutierrez PR, et al. National eye institute visual function questionnaire field test investigators. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001;119:1050–8.CrossRef Mangione CM, Lee PP, Gutierrez PR, et al. National eye institute visual function questionnaire field test investigators. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001;119:1050–8.CrossRef
15.
Zurück zum Zitat White D, Leach C, Sims R, Atkinson M, Cottrell D. Validation of the hospital anxiety and depression scale for use with adolescents. Br J Psychiatry. 1999;175:452–4.CrossRef White D, Leach C, Sims R, Atkinson M, Cottrell D. Validation of the hospital anxiety and depression scale for use with adolescents. Br J Psychiatry. 1999;175:452–4.CrossRef
16.
Zurück zum Zitat Hermann C. International experiences with the hospital anxiety and depression scale—a review of validation data and clinical results. J Psychosom Res. 1997;42:17–41.CrossRef Hermann C. International experiences with the hospital anxiety and depression scale—a review of validation data and clinical results. J Psychosom Res. 1997;42:17–41.CrossRef
17.
Zurück zum Zitat Snaith RP. The hospital anxiety and depression (HADS) scale. Qual life Newsl. 1993;6:5. Snaith RP. The hospital anxiety and depression (HADS) scale. Qual life Newsl. 1993;6:5.
18.
Zurück zum Zitat Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70.CrossRef Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70.CrossRef
19.
Zurück zum Zitat Ware JE Jr, Kosinski M, Turner-Bowker DM, Sundaram M, Gandek B, Maruish ME. SF-12v2 Health Survey: administration guide for clinical trial investigators. Lincoln: QualityMetric; 2009. Ware JE Jr, Kosinski M, Turner-Bowker DM, Sundaram M, Gandek B, Maruish ME. SF-12v2 Health Survey: administration guide for clinical trial investigators. Lincoln: QualityMetric; 2009.
27.
Zurück zum Zitat Jo C. Cost-of-illness studies: concepts, scopes, and methods. Clin Mol Hepatol. 2014;20:327–37.CrossRef Jo C. Cost-of-illness studies: concepts, scopes, and methods. Clin Mol Hepatol. 2014;20:327–37.CrossRef
28.
Zurück zum Zitat Bourne RRA, Flaxman SR, Braithwaite T, et al. Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis. Lancet Global Health. 2017;5(9):e888–97.CrossRef Bourne RRA, Flaxman SR, Braithwaite T, et al. Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis. Lancet Global Health. 2017;5(9):e888–97.CrossRef
29.
Zurück zum Zitat IBGE - Instituto Brasileiro de Geografia e Estatística. Pesquisa Nacional por Amostra de Domicílios: síntese de indicadores 2014/IBGE, Coordenação de Trabalho e Rendimento. - Rio de Janeiro: IBGE, 2015; 2015. 102 p. IBGE - Instituto Brasileiro de Geografia e Estatística. Pesquisa Nacional por Amostra de Domicílios: síntese de indicadores 2014/IBGE, Coordenação de Trabalho e Rendimento. - Rio de Janeiro: IBGE, 2015; 2015. 102 p.
30.
Zurück zum Zitat Marback RF, Maia Júnior OO, Morais FB, Takahashi WY. Quality of life in patients with age-related macular degeneration with monocular and binocular legal blindness. Clinics. 2007;62(5):573–8.CrossRef Marback RF, Maia Júnior OO, Morais FB, Takahashi WY. Quality of life in patients with age-related macular degeneration with monocular and binocular legal blindness. Clinics. 2007;62(5):573–8.CrossRef
31.
Zurück zum Zitat Chong EW, Lamoureux EL, Jenkins MA, et al. Sociodemographic, lifestyle, and medical risk factors for visual impairment in an urban Asian population: the Singapore Malay Eye Study. Arch Ophthalmol. 2009;127:1640–7.CrossRef Chong EW, Lamoureux EL, Jenkins MA, et al. Sociodemographic, lifestyle, and medical risk factors for visual impairment in an urban Asian population: the Singapore Malay Eye Study. Arch Ophthalmol. 2009;127:1640–7.CrossRef
32.
Zurück zum Zitat Cheng ACK, Pang CP, Leung ATS, Chua JKH, Fan DSP, Lam DSC. The association between cigarette smoking and ocular diseases. Hong Kong Med J. 2000;6:195–202.PubMed Cheng ACK, Pang CP, Leung ATS, Chua JKH, Fan DSP, Lam DSC. The association between cigarette smoking and ocular diseases. Hong Kong Med J. 2000;6:195–202.PubMed
33.
Zurück zum Zitat Bressler NM, Chang TS, Suñer IJ, et al. Vision-related function after ranibizumab treatment by better or worse-seeing eye: clinical trial results from MARINA and ANCHOR. Ophthalmology. 2010;117:747–56.CrossRef Bressler NM, Chang TS, Suñer IJ, et al. Vision-related function after ranibizumab treatment by better or worse-seeing eye: clinical trial results from MARINA and ANCHOR. Ophthalmology. 2010;117:747–56.CrossRef
34.
Zurück zum Zitat Bressler NM, Varma R, Suñer IJ, et al. Vision-related function after ranibizumab treatment for diabetic macular edema: results from RIDE and RISE. Ophthalmology. 2014;121:2461–72.CrossRef Bressler NM, Varma R, Suñer IJ, et al. Vision-related function after ranibizumab treatment for diabetic macular edema: results from RIDE and RISE. Ophthalmology. 2014;121:2461–72.CrossRef
35.
Zurück zum Zitat Bertelmann T, Feltgen N, Scheffler M, et al. Vision-related quality of life in patients receiving intravitreal ranibizumab injections in routine clinical practice: baseline data from the German OCEAN study. Health Qual Life Outcomes. 2016;14(1):132.CrossRef Bertelmann T, Feltgen N, Scheffler M, et al. Vision-related quality of life in patients receiving intravitreal ranibizumab injections in routine clinical practice: baseline data from the German OCEAN study. Health Qual Life Outcomes. 2016;14(1):132.CrossRef
36.
Zurück zum Zitat Evans JR, Fletcher AE, Wormald RP. Depression and anxiety in visually impaired older people. Ophthalmology. 2007;114(2):283–8.CrossRef Evans JR, Fletcher AE, Wormald RP. Depression and anxiety in visually impaired older people. Ophthalmology. 2007;114(2):283–8.CrossRef
37.
Zurück zum Zitat van der Aa HP, Comijs HC, Penninx BW, van Rens GH, van Nispen RM. Major depressive and anxiety disorders in visually impaired older adults. Invest Ophthalmol Vis Sci. 2015;56(2):849–54.CrossRef van der Aa HP, Comijs HC, Penninx BW, van Rens GH, van Nispen RM. Major depressive and anxiety disorders in visually impaired older adults. Invest Ophthalmol Vis Sci. 2015;56(2):849–54.CrossRef
38.
Zurück zum Zitat Heesterbeek TJ, van der Aa HPA, van Rens G, Twisk JWR, van Nispen RMA. The incidence and predictors of depressive and anxiety symptoms in older adults with vision impairment: a longitudinal prospective cohort study. Ophthalmic Physiol Opt. 2017;37(4):385–98.CrossRef Heesterbeek TJ, van der Aa HPA, van Rens G, Twisk JWR, van Nispen RMA. The incidence and predictors of depressive and anxiety symptoms in older adults with vision impairment: a longitudinal prospective cohort study. Ophthalmic Physiol Opt. 2017;37(4):385–98.CrossRef
40.
Zurück zum Zitat Brasil. Ministério da Saúde. Portaria nº 3.129, de 24 de dezembro de 2008. Brasil. Ministério da Saúde. Portaria nº 3.129, de 24 de dezembro de 2008.
41.
Zurück zum Zitat Brasil. Ministério da Saúde. Portaria nº 3.128, de 24 de dezembro de 2008. Brasil. Ministério da Saúde. Portaria nº 3.128, de 24 de dezembro de 2008.
Metadaten
Titel
Humanistic and Economic Burden of Blindness Associated with Retinal Disorders in a Brazilian Sample: A Cross-Sectional Study
verfasst von
Nilceia Lopes
Leticia Lucia dos Santos Dias
Marcos Ávila
Ricardo Miguel Japiassú
Cristina Muccioli
Arnaldo Furman Bordon
Tiago Eugênio Arantes
Tatiana Tanaka
João Jorge Nassaralla Júnior
Antonio Marcelo Casella
Márcio Bittar Nehemy
Magno Ferreira
Rogério Furquim Mauad
Publikationsdatum
31.03.2021
Verlag
Springer Healthcare
Erschienen in
Advances in Therapy / Ausgabe 8/2021
Print ISSN: 0741-238X
Elektronische ISSN: 1865-8652
DOI
https://doi.org/10.1007/s12325-021-01672-3

Weitere Artikel der Ausgabe 8/2021

Advances in Therapy 8/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.